NRG Oncology Semiannual Meeting - Jan 25, 2019 - Pres time: Feb 7, 2019; "Thursday, February 7, 2019, 4:35-4:50PM, Project Team Member Applications:U- nderstanding PTMA; February 8-9, 2019, 8:00 am - 10:00 am, Review of Active Studies: NRG-GY009 A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and Atezolizumab vs Pegylated Liposomal Doxorubicin/Bevacizumab and Atezolizumab vs Pegylated Liposomal Doxorubicin/Bevacizumab in Platinum Resistant Ovarian Cancer; Saturday, February 9, 2019; 10:00 AM – 12:00 PM, Gynecologic Cancer Workshop Committee; Chair: Carol Aghajanian, MD."
CME
|